Philip A. McFarlane

8.0k total citations
76 papers, 2.5k citations indexed

About

Philip A. McFarlane is a scholar working on Nephrology, Emergency Medical Services and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip A. McFarlane has authored 76 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Nephrology, 18 papers in Emergency Medical Services and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip A. McFarlane's work include Dialysis and Renal Disease Management (33 papers), Central Venous Catheters and Hemodialysis (18 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Philip A. McFarlane is often cited by papers focused on Dialysis and Renal Disease Management (33 papers), Central Venous Catheters and Hemodialysis (18 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Philip A. McFarlane collaborates with scholars based in Canada, United Kingdom and United States. Philip A. McFarlane's co-authors include Andreas Pierratos, Christopher T. Chan, Niki Dacouris, Marc B. Goldstein, Donald A. Redelmeier, Ahmed M. Bayoumi, Patrick J. Hanly, Jaime M. Beecroft, David C. Mendelssohn and Peter Senior and has published in prestigious journals such as Blood, Diabetes and The FASEB Journal.

In The Last Decade

Philip A. McFarlane

74 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip A. McFarlane Canada 28 1.3k 613 395 390 387 76 2.5k
Tariq Shafi United States 36 1.8k 1.4× 300 0.5× 554 1.4× 499 1.3× 491 1.3× 150 3.7k
Robert Richardson Canada 33 1.8k 1.4× 636 1.0× 684 1.7× 140 0.4× 700 1.8× 74 3.0k
A.J. Collins United States 17 1.7k 1.3× 236 0.4× 232 0.6× 204 0.5× 261 0.7× 25 2.7k
Justin M. Albert United States 16 3.1k 2.4× 428 0.7× 489 1.2× 207 0.5× 612 1.6× 18 3.6k
Ionuţ Nistor Romania 31 1.6k 1.2× 283 0.5× 745 1.9× 247 0.6× 379 1.0× 92 2.9k
Philip G. Zager United States 32 2.0k 1.5× 218 0.4× 657 1.7× 480 1.2× 325 0.8× 88 3.2k
Robert M. Lindsay Canada 25 1.9k 1.5× 817 1.3× 579 1.5× 82 0.2× 226 0.6× 73 2.2k
Nancy L. Lew United States 22 3.2k 2.5× 869 1.4× 934 2.4× 201 0.5× 501 1.3× 23 3.9k
Lorien S. Dalrymple United States 29 1.6k 1.3× 157 0.3× 400 1.0× 138 0.4× 188 0.5× 57 2.8k
John J. Sim United States 31 1.4k 1.1× 107 0.2× 483 1.2× 474 1.2× 576 1.5× 117 3.4k

Countries citing papers authored by Philip A. McFarlane

Since Specialization
Citations

This map shows the geographic impact of Philip A. McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. McFarlane more than expected).

Fields of papers citing papers by Philip A. McFarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. McFarlane. The network helps show where Philip A. McFarlane may publish in the future.

Co-authorship network of co-authors of Philip A. McFarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. McFarlane. A scholar is included among the top collaborators of Philip A. McFarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. McFarlane. Philip A. McFarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldenberg, Ronald, Christopher T. Chan, David Z.I. Cherney, et al.. (2017). Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New. Canadian Journal of Diabetes. 42(3). 325–334. 12 indexed citations
2.
Davies, Evan, Louis S. Matza, David Feeny, et al.. (2015). Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health and Quality of Life Outcomes. 13(1). 90–90. 29 indexed citations
3.
Teoh, Hwee, Jean‐Pierre Després, Robert Dufour, et al.. (2013). Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?. Canadian Journal of Cardiology. 29(8). 960–968. 14 indexed citations
4.
5.
Wald, Ron, Andrew T. Yan, Jeffrey Perl, et al.. (2012). Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. BMC Nephrology. 13(1). 3–3. 25 indexed citations
6.
Casanova, Amparo, Hwee Teoh, Hertzel C. Gerstein, et al.. (2012). Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study. International Journal of Clinical Practice. 66(5). 457–464. 35 indexed citations
7.
McFarlane, Philip A.. (2011). Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival. Current Opinion in Nephrology & Hypertension. 20(2). 182–188. 15 indexed citations
8.
Bernard, Brandon, et al.. (2011). Pulmonary vascular calcification in a nocturnal hemodialysis patient. Clinical Nephrology. 77(3). 231–236. 3 indexed citations
9.
Casanova, Amparo, Hwee Teoh, Keith Dawson, et al.. (2010). Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Canadian Journal of Cardiology. 26(6). 297–302. 70 indexed citations
10.
McFarlane, Philip A.. (2010). Should Patients Remain on Intensive Hemodialysis Rather than Choosing to Receive a Kidney Transplant?. Seminars in Dialysis. 23(5). 516–519. 19 indexed citations
11.
Donnelly, Sandra, Philip A. McFarlane, Christopher T. Chan, et al.. (2009). Glutathione and Riboflavin Status in Supplemented Patients Undergoing Home Nocturnal Hemodialysis versus Standard Hemodialysis. Journal of Renal Nutrition. 20(3). 199–208. 9 indexed citations
12.
Marticorena, Rosa M., et al.. (2009). A simple method to create buttonhole cannulation tracks in a busy hemodialysis unit. Hemodialysis International. 13(3). 316–321. 25 indexed citations
13.
McFarlane, Philip A.. (2008). Lessons for dialysis investigators from the Steno-2 Study. Journal of Nephrology. 21(1). 6–13. 2 indexed citations
14.
McFarlane, Philip A., Michael Hillmer, & Niki Dacouris. (2007). A Change from Subcutaneous to Intravenous Erythropoietin Increases the Cost of Anemia Therapy. Nephron Clinical Practice. 107(3). c90–c96. 11 indexed citations
15.
McFarlane, Philip A., Andreas Pierratos, Ahmed M. Bayoumi, & Donald A. Redelmeier. (2007). Estimating Preference Scores in Conventional and Home Nocturnal Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 2(3). 477–483. 11 indexed citations
16.
Beecroft, Jaime M., James Duffin, Andreas Pierratos, et al.. (2006). Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. European Respiratory Journal. 28(1). 151–158. 93 indexed citations
17.
McFarlane, Philip A. & Ahmed M. Bayoumi. (2004). Acceptance and rejection: Cost-effectiveness and the working nephrologist. Kidney International. 66(5). 1735–1741. 18 indexed citations
18.
McFarlane, Philip A., Ahmed M. Bayoumi, Andreas Pierratos, & Donald A. Redelmeier. (2003). The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney International. 64(3). 1004–1011. 131 indexed citations
19.
Prasad, G. V. Ramesh, Michelle M. Nash, Philip A. McFarlane, & Jeffrey S. Zaltzman. (2003). Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clinical Transplantation. 17(2). 135–139. 48 indexed citations
20.
McFarlane, Philip A., Andreas Pierratos, & Donald A. Redelmeier. (2002). Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney International. 62(6). 2216–2222. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tariq Shafi Breakdown of academic impact, for papers by Robert Richardson Breakdown of academic impact, for papers by A.J. Collins Breakdown of academic impact, for papers by Justin M. Albert Breakdown of academic impact, for papers by Ionuţ Nistor Breakdown of academic impact, for papers by Philip G. Zager Breakdown of academic impact, for papers by Robert M. Lindsay Breakdown of academic impact, for papers by Nancy L. Lew Breakdown of academic impact, for papers by Lorien S. Dalrymple Breakdown of academic impact, for papers by John J. Sim
Rankless by CCL
2026